Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margarita Lianeri

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Molecular Biology Reports|November 19, 2010
Apicidin suppresses transcription of 17β-hydroxysteroid dehydrogenase type 1 in endometrial adenocarcinoma cellsElif Keleş, Margarita Lianeri, Paweł Piotr Jagodziński
Genetic Testing and Molecular Biomarkers|April 7, 2012
Prevalence of the NKG2D Thr72Ala polymorphism in patients with cervical carcinomaAndrzej Roszak, Margarita Lianeri, Paweł P Jagodziński
The International Journal of Biological Markers|September 20, 2011
Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinomaAndrzej Roszak, Margarita Lianeri, Pawel P Jagodzinski
Current Genomics|March 22, 2014
Molecular Effects of L-dopa Therapy in Parkinson's DiseaseJolanta Dorszewska, Michal Prendecki, Margarita Lianeri, et al.
Current Genomics|March 22, 2014
Genetic variants in diseases of the extrapyramidal systemAnna Oczkowska, Wojciech Kozubski, Margarita Lianeri, et al.
Molecular Biology Reports|October 27, 2016
Exploring estrogenic activity in lung cancerBartosz Kazimierz Słowikowski, Margarita Lianeri, Paweł Piotr Jagodziński
Current Genomics|February 18, 2014
Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's DiseaseAnna Oczkowska, Wojciech Kozubski, Margarita Lianeri, et al.
Molecular Diagnosis & Therapy|March 15, 2014
CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish populationAndrzej Roszak, Margarita Lianeri, Anna Sowińska, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 20, 2016
The role and impact of estrogens and xenoestrogen on the development of cervical cancerDorota Ewa Bronowicka-Kłys, Margarita Lianeri, Paweł Piotr Jagodziński
Molecular Diagnosis & Therapy|May 2, 2013
Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian womenAndrzej Roszak, Margarita Lianeri, Anna Sowińska, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Molecular Biology Reports|November 19, 2010
Apicidin suppresses transcription of 17β-hydroxysteroid dehydrogenase type 1 in endometrial adenocarcinoma cellsElif Keleş, Margarita Lianeri, Paweł Piotr Jagodziński
Genetic Testing and Molecular Biomarkers|April 7, 2012
Prevalence of the NKG2D Thr72Ala polymorphism in patients with cervical carcinomaAndrzej Roszak, Margarita Lianeri, Paweł P Jagodziński
The International Journal of Biological Markers|September 20, 2011
Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinomaAndrzej Roszak, Margarita Lianeri, Pawel P Jagodzinski
Current Genomics|March 22, 2014
Molecular Effects of L-dopa Therapy in Parkinson's DiseaseJolanta Dorszewska, Michal Prendecki, Margarita Lianeri, et al.
Current Genomics|March 22, 2014
Genetic variants in diseases of the extrapyramidal systemAnna Oczkowska, Wojciech Kozubski, Margarita Lianeri, et al.
Molecular Biology Reports|October 27, 2016
Exploring estrogenic activity in lung cancerBartosz Kazimierz Słowikowski, Margarita Lianeri, Paweł Piotr Jagodziński
Current Genomics|February 18, 2014
Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's DiseaseAnna Oczkowska, Wojciech Kozubski, Margarita Lianeri, et al.
Molecular Diagnosis & Therapy|March 15, 2014
CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish populationAndrzej Roszak, Margarita Lianeri, Anna Sowińska, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 20, 2016
The role and impact of estrogens and xenoestrogen on the development of cervical cancerDorota Ewa Bronowicka-Kłys, Margarita Lianeri, Paweł Piotr Jagodziński
Molecular Diagnosis & Therapy|May 2, 2013
Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian womenAndrzej Roszak, Margarita Lianeri, Anna Sowińska, et al.
Pageof 9